| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
61,364 |
51,617 |
$12.44M |
| 90832 |
Psychotherapy, 30 minutes with patient |
14,404 |
10,508 |
$2.75M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,133 |
9,662 |
$1.99M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,865 |
6,762 |
$1.37M |
| 90837 |
Psychotherapy, 53 minutes with patient |
4,211 |
2,859 |
$713K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
9,840 |
7,190 |
$578K |
| Q3014 |
Telehealth originating site facility fee |
8,152 |
5,986 |
$304K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,487 |
1,138 |
$271K |
| 97803 |
|
1,512 |
1,347 |
$271K |
| 99441 |
|
1,721 |
1,547 |
$267K |
| 90791 |
Psychiatric diagnostic evaluation |
1,323 |
1,235 |
$246K |
| 3008F |
|
53,124 |
44,075 |
$157K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
730 |
693 |
$154K |
| G0470 |
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit |
2,710 |
1,911 |
$141K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
650 |
629 |
$135K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
381 |
370 |
$76K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
466 |
435 |
$63K |
| 99215 |
Prolong outpt/office vis |
291 |
258 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,602 |
1,749 |
$45K |
| 99442 |
|
205 |
189 |
$41K |
| 98968 |
|
172 |
144 |
$31K |
| 92250 |
|
2,353 |
2,245 |
$26K |
| 0012A |
|
486 |
478 |
$17K |
| 0011A |
|
441 |
431 |
$12K |
| 0064A |
|
467 |
415 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,672 |
4,352 |
$9K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
92 |
74 |
$8K |
| 99201 |
|
52 |
51 |
$8K |
| 97802 |
|
25 |
24 |
$7K |
| 99443 |
|
32 |
25 |
$6K |
| 82962 |
|
38 |
29 |
$6K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
82 |
78 |
$5K |
| 86580 |
|
84 |
71 |
$5K |
| 3078F |
|
4,411 |
3,703 |
$5K |
| 3079F |
|
2,531 |
2,199 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
14 |
$3K |
| V2020 |
Frames, purchases |
581 |
567 |
$2K |
| 1036F |
|
2,434 |
2,074 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
14 |
13 |
$2K |
| 0134A |
|
179 |
149 |
$2K |
| 0004A |
|
69 |
59 |
$2K |
| 3074F |
|
4,015 |
3,426 |
$1K |
| 1034F |
|
772 |
630 |
$1K |
| 90670 |
|
15 |
12 |
$1K |
| 91322 |
|
220 |
201 |
$1K |
| 0013A |
|
36 |
34 |
$956.63 |
| 90686 |
|
2,479 |
2,291 |
$892.41 |
| 90715 |
|
243 |
233 |
$883.64 |
| 3075F |
|
1,518 |
1,285 |
$880.64 |
| 3077F |
|
2,917 |
2,439 |
$880.64 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
8,019 |
7,170 |
$863.40 |
| 3080F |
|
1,480 |
1,287 |
$664.66 |
| 80305 |
|
18 |
15 |
$554.52 |
| G0008 |
Administration of influenza virus vaccine |
453 |
368 |
$434.48 |
| 96127 |
|
149 |
140 |
$301.04 |
| 36415 |
Collection of venous blood by venipuncture |
585 |
545 |
$258.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
216 |
198 |
$226.44 |
| 3044F |
|
565 |
463 |
$220.16 |
| 3045F |
|
56 |
46 |
$220.16 |
| 4004F |
|
234 |
202 |
$220.16 |
| 90480 |
|
220 |
201 |
$207.36 |
| 92015 |
Determination of refractive state |
1,352 |
1,299 |
$148.37 |
| 90656 |
|
102 |
101 |
$39.15 |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
240 |
236 |
$28.88 |
| V2756 |
Eye glass case |
710 |
693 |
$25.43 |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
93 |
90 |
$6.75 |
| 91301 |
|
661 |
628 |
$0.62 |
| 91306 |
|
110 |
108 |
$0.16 |
| 91300 |
|
29 |
26 |
$0.02 |
| 91313 |
|
180 |
150 |
$0.01 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
246 |
219 |
$0.00 |
| 1111F |
|
87 |
74 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
335 |
297 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
234 |
206 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
195 |
166 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
52 |
39 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
126 |
111 |
$0.00 |
| 3500F |
|
16 |
14 |
$0.00 |
| 99385 |
|
12 |
12 |
$0.00 |
| 1000F |
|
66 |
62 |
$0.00 |
| 90674 |
|
20 |
20 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
17 |
14 |
$0.00 |
| G9908 |
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
52 |
47 |
$0.00 |
| 1160F |
|
796 |
736 |
$0.00 |
| 1159F |
|
187 |
169 |
$0.00 |
| 3046F |
|
127 |
96 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
180 |
172 |
$0.00 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
56 |
37 |
$0.00 |
| 81002 |
|
16 |
14 |
$0.00 |
| 3051F |
|
27 |
25 |
$0.00 |
| G9905 |
Patient not screened for tobacco use |
14 |
13 |
$0.00 |
| 81025 |
|
15 |
15 |
$0.00 |